Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis
The second messenger 2′3′-cyclic-GMP-AMP (cGAMP) is thought to be transmitted from brain carcinomas to astrocytes via gap junctions, which functions to promote metastasis in the brain parenchyma. In the current study, we established a method to introduce cGAMP into astrocytes, which simulates the st...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/9028 |
id |
doaj-4d809ad0da4e41ec86d595507387be36 |
---|---|
record_format |
Article |
spelling |
doaj-4d809ad0da4e41ec86d595507387be362021-08-26T13:53:42ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-01229028902810.3390/ijms22169028Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain MetastasisToya Okawa0Kurumi Hara1Momoko Goto2Moe Kikuchi3Masataka Kogane4Hiroto Hatakeyama5Hiroki Tanaka6Daiki Shirane7Hidetaka Akita8Akihiro Hisaka9Hiromi Sato10Clinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanDesign and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanDesign and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanDesign and Drug Disposition, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanClinical Pharmacology and Pharmacometrics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8675, JapanThe second messenger 2′3′-cyclic-GMP-AMP (cGAMP) is thought to be transmitted from brain carcinomas to astrocytes via gap junctions, which functions to promote metastasis in the brain parenchyma. In the current study, we established a method to introduce cGAMP into astrocytes, which simulates the state of astrocytes that have been invaded by cGAMP around tumors. Astrocytes incorporating cGAMP were analyzed by metabolomics, which demonstrated that cGAMP increased glutamate production and astrocyte secretion. The same trend was observed for γ-aminobutyric acid (GABA). Conversely, glutamine production and secretion were decreased by cGAMP treatment. Due to the fundamental role of astrocytes in regulation of the glutamine–glutamate cycle, such metabolic changes may represent a potential mechanism and therapeutic target for alteration of the central nervous system (CNS) environment and the malignant transformation of brain carcinomas.https://www.mdpi.com/1422-0067/22/16/9028cGAMPmetabolome shiftastrocytemetastatic brain tumorglutamate |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Toya Okawa Kurumi Hara Momoko Goto Moe Kikuchi Masataka Kogane Hiroto Hatakeyama Hiroki Tanaka Daiki Shirane Hidetaka Akita Akihiro Hisaka Hiromi Sato |
spellingShingle |
Toya Okawa Kurumi Hara Momoko Goto Moe Kikuchi Masataka Kogane Hiroto Hatakeyama Hiroki Tanaka Daiki Shirane Hidetaka Akita Akihiro Hisaka Hiromi Sato Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis International Journal of Molecular Sciences cGAMP metabolome shift astrocyte metastatic brain tumor glutamate |
author_facet |
Toya Okawa Kurumi Hara Momoko Goto Moe Kikuchi Masataka Kogane Hiroto Hatakeyama Hiroki Tanaka Daiki Shirane Hidetaka Akita Akihiro Hisaka Hiromi Sato |
author_sort |
Toya Okawa |
title |
Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis |
title_short |
Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis |
title_full |
Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis |
title_fullStr |
Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis |
title_full_unstemmed |
Effects on Metabolism in Astrocytes Caused by cGAMP, Which Imitates the Initial Stage of Brain Metastasis |
title_sort |
effects on metabolism in astrocytes caused by cgamp, which imitates the initial stage of brain metastasis |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-08-01 |
description |
The second messenger 2′3′-cyclic-GMP-AMP (cGAMP) is thought to be transmitted from brain carcinomas to astrocytes via gap junctions, which functions to promote metastasis in the brain parenchyma. In the current study, we established a method to introduce cGAMP into astrocytes, which simulates the state of astrocytes that have been invaded by cGAMP around tumors. Astrocytes incorporating cGAMP were analyzed by metabolomics, which demonstrated that cGAMP increased glutamate production and astrocyte secretion. The same trend was observed for γ-aminobutyric acid (GABA). Conversely, glutamine production and secretion were decreased by cGAMP treatment. Due to the fundamental role of astrocytes in regulation of the glutamine–glutamate cycle, such metabolic changes may represent a potential mechanism and therapeutic target for alteration of the central nervous system (CNS) environment and the malignant transformation of brain carcinomas. |
topic |
cGAMP metabolome shift astrocyte metastatic brain tumor glutamate |
url |
https://www.mdpi.com/1422-0067/22/16/9028 |
work_keys_str_mv |
AT toyaokawa effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT kurumihara effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT momokogoto effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT moekikuchi effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT masatakakogane effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT hirotohatakeyama effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT hirokitanaka effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT daikishirane effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT hidetakaakita effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT akihirohisaka effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis AT hiromisato effectsonmetabolisminastrocytescausedbycgampwhichimitatestheinitialstageofbrainmetastasis |
_version_ |
1721192470961717248 |